Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 11, 2021 09:00 ET | Source: Constellation Pharmaceuticals , Inc.

Constellation Pharmaceuticals Provides an Update from the Ongoing MANIFEST Study of Pelabresib

Translational data support the disease-modifying potential of pelabresibCentral pathology review confirmed bone marrow fibrosis improvements observed with pelabresib treatment Impact of pelabresib...
May 31, 2021 09:00 ET | Source: Constellation Pharmaceuticals , Inc.

Constellation Pharmaceuticals to Participate in Jefferies Virtual Healthcare Conference

CAMBRIDGE, Mass., May 31, 2021 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals, Inc. (Nasdaq: CNST), a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover...
May 10, 2021 07:00 ET | Source: Constellation Pharmaceuticals , Inc.

Constellation Pharmaceuticals Announces First-Quarter 2021 Financial Results and Provides Business Update

Dosing underway in the Phase 3 MANIFEST-2 clinical trialRecommended Phase 2 dose determined for CPI-0209 and first patient dosed in the Phase 2 expansion cohortsUpcoming data presentation at ASCO...
April 27, 2021 11:30 ET | Source: Constellation Pharmaceuticals , Inc.

Constellation Pharmaceuticals to Host Conference Call to Discuss First Quarter 2021 Results

CAMBRIDGE, Mass., April 27, 2021 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel...
February 24, 2021 07:00 ET | Source: Constellation Pharmaceuticals , Inc.

Constellation Pharmaceuticals Announces Fourth-Quarter and Full-Year 2020 Financial Results

CAMBRIDGE, Mass., Feb. 24, 2021 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop...
February 19, 2021 16:00 ET | Source: Constellation Pharmaceuticals , Inc.

Constellation Pharmaceuticals to Participate in the 10th Annual SVB Leerink Global Healthcare Conference

CAMBRIDGE, Mass., Feb. 19, 2021 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals, Inc. (Nasdaq: CNST), a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover...
February 18, 2021 10:00 ET | Source: Constellation Pharmaceuticals , Inc.

Constellation Pharmaceuticals to Host Conference Call to Discuss Fourth Quarter 2020 Results

CAMBRIDGE, Mass., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop...